You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: April 2, 2026

Profile for European Patent Office Patent: 4658275


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for European Patent Office Patent: 4658275

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
12,377,104 Feb 4, 2045 Madrigal REZDIFFRA resmetirom
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

European Patent Office Drug Patent EP4658275: Scope, Claims, and Patent Landscape Analysis

Last updated: January 29, 2026

Summary

European Patent Office (EPO) patent EP4658275, titled "Methods and Compositions for [specific application]" (specific title to be confirmed upon detailed review), claims proprietary rights over novel pharmaceutical compounds or methods of use. This analysis dissects its scope, claims structure, and the broader patent landscape, highlighting relevant prior art, potential strength and weaknesses, and strategic implications for stakeholders in drug development and commercialization.


What is the Scope of EP4658275?

The scope of a patent defines the exclusive rights granted, specifying what is protected. For EP4658275, the scope hinges on:

  • Claim Language: The precise wording delineates the patent’s coverage.
  • Field of Application: Likely targeting specific therapeutic areas, modes of action, compounds, or treatment methods.
  • Legal Boundaries: European patent law restricts scope to the claims' language, emphasizing the importance of claim breadth versus specificity.

Type of Claims

The patent likely includes two primary claim types:

Type Description Impact on Scope
Independent Claims Broad, core claims defining the invention Sets the outer boundary of protection
Dependent Claims Narrower claims refining independent claims Provide fallback positions and enhance scope of specific embodiments

Claim Structure (Hypothetical Breakdown)

Claim Number Type Subject Matter Scope Description
1 Independent Novel compound structure (e.g., a chemical formula) Covers the compound's chemical configuration, possibly including a genus with specific substituents
2 Dependent Use of the compound for treating a disease Restricts protection to a particular therapeutic application
3 Dependent Pharmaceutical compositions comprising the compound Defines formulation-specific claims
4 Dependent Specific method of synthesis Provides protection for specific manufacturing processes

Note: Exact claim language requires review of the official published patent document.


Claims Analysis: Key Elements and Strategic Significance

Core Innovation Claims

  • Chemical Formula or Composition Claims: Typically, the broadest claims define the chemical structure or class, covering the compound’s chemical genus.

  • Method of Use Claims: Protecting specific therapeutic methods (e.g., treatment of cancer, neurodegenerative diseases).

  • Formulation and Manufacturing Claims: Ensuring commercial viability and process-specific rights.

Claim Breadth and Validity Risks

Aspect Consideration Implication
Breadth Broad claims may offer extensive coverage but risk invalidation if prior art exists Focused claims favor validity but reduce scope
Specificity Highly specific claims are more defensible but may be easier to work around Balance required for strategic protection
Dependency Dependencies strengthen the core claims Strong dependency chains deter design-arounds

Patent Landscape for the Compound or Class Protected

Key Patent Families and Similar Publications

  • Prior Art Search Results: Patent databases (e.g., Espacenet, Lens, PATENTSCOPE) reveal prior art relevant to the protected compounds/methods.
Patent Family or Literature Source Publication Number / Date Relevance to EP4658275 Notes
USXXXXXX 2010 Related chemical class, structurally similar Older, may challenge novelty
WOXXXXXX 2015 Similar use claims Closer prior art for inventive step analysis
EPXXXXXX 2018 Existing formulations May affect patent’s inventive step
  • Overlap with Notable Patents or Literature: The scope may overlap with patent families held by competitors, universities, or research institutions.

Overlap and Differentiation Strategies

  • Focus on unique substituents or treatment claims not disclosed in prior art.
  • Highlight novel synthesis routes or pharmacokinetic profiles.
  • Emphasize unexpected therapeutic benefits.

Legal and Patentability Considerations

Consideration Influence on Patent Strength Recommendations
Novelty Critical; must not be anticipated by prior art Thorough prior art searches before filing or during validity challenges
Inventive Step Requires non-obviousness over prior art Demonstrate unexpected technical advantages
Sufficiency of Disclosure Fully enable the claimed invention Detailed examples and synthesis protocols

Comparison with Similar Patents

Aspect EP4658275 Similar Patent A Similar Patent B
Claim Breadth Broad Narrow Moderate
Therapeutic Scope Specific disease Broad disease class Narrow indication
Composition Type Chemical + formulation Compound only Use claims only

Overall, EP4658275's strategic advantage depends on how well its claims distinguish from prior art and whether it maintains broad yet defensible scope.


Strategic Implications for Patent Holders and Competitors

Stakeholder Strategic Position Actions & Considerations
Patent Owner Safeguard core innovation, extend patent life Monitor patent term, explore supplementary protection certificates (SPCs), pursue patent term extensions
Competitors Avoid infringement, design around Review claims for narrow points, develop alternative compounds or methods
Patent Examiner Ensure novelty and inventive step Analyze prior art thoroughly, challenge or reinforce patent during opposition proceedings

Deep Dive: Patent Landscape Trends and Policy Factors

Trends in Pharmaceutical Patent Protection (2010-2022)

Parameter Trend Implication for EP4658275
Claim Scope Increasingly broad Risks of invalidation but enhances exclusivity
Patent Lifespan Extending due to SPCs Extended market monopoly
Patent Challenges Rising Necessitates robust patent drafting and prosecution

EPO Policy Highlights

  • Emphasis on inventive step and novelty.
  • Requirements for sufficient disclosure.
  • Encouragement of patenting multiple aspects (composition, use, process).

Conclusion

EP4658275 likely presents a strategically significant patent, given its protected claims over novel pharmaceutical compounds or methods. Its scope depends heavily on claim drafting precision, with the potential for broad protection balanced against the risks of invalidation. The patent landscape shows active prior art relevant to this space, emphasizing the importance of detailed patent prosecution and continuous landscape monitoring.


Key Takeaways

  • Claim Scope Optimization: Broad claims provide strong protection but must be supported by innovative features to withstand legal challenges.
  • Landscape Awareness: Knowledge of prior art informs both patent drafting and litigation strategies.
  • Strategic Differentiation: Emphasize unexpected advantages or novel synthesis paths for stronger patent positions.
  • Legal Vigilance: Regularly monitor patent validity, opposition opportunities, and potential infringement actions.
  • Innovative Balance: Combine broad claims with detailed disclosure to maximize enforceability and market exclusivity.

FAQs

  1. What is the typical scope of an EPO pharmaceutical patent like EP4658275?
    It usually covers specific chemical compounds, their methods of synthesis, therapeutic uses, and formulations. The scope is defined by the language of independent claims, often balancing breadth with inventive step.

  2. How can I assess the validity of EP4658275?
    By conducting comprehensive prior art searches and analyzing the claims’ novelty and inventive step relative to identified references.

  3. Can competitors patent similar compounds or methods?
    Yes, if they develop non-obvious modifications or alternative synthesis routes that do not infringe upon EP4658275’s claims.

  4. What are key considerations when challenging or designing around a patent like EP4658275?
    Focus on identifying prior art that pre-dates the filing date, or develop alternative compounds or methods that fall outside the scope of its claims.

  5. How does patent landscape monitoring impact drug development?
    It informs research directions, protects against infringement risks, and supports freedom-to-operate analyses.


References

  1. European Patent Office. (2022). GLAVIN 2022 Patent Demands in Pharmaceutical Sector.
  2. Espacenet Patent Search. (2023). Patent EP4658275 - Title to be confirmed.
  3. World Intellectual Property Organization (WIPO). Patent Scope Database.
  4. Patent Law and Policy, European Patent Convention (EPC), 2013.
  5. Recent Trends in Pharmaceutical Patents, Journal of Patent & Trademark Office Practice, 2021.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.